EMBO Conference on Innate Lymphoid Cells

 

Paris, September 29th - October 1st 2014

Overview

The study of Innate Lymphoid Cells (ILCs) is a strong emergent field in immunology that is having a major impact on our understanding of the early events unfolding during an immune response. While subsets of ILCs (NK cells, LTi cells) have been recognized for more than 10 years, the realization that ILCs constitute a larger family that mirrors the activity of differentiated T cells has only become apparent in the last few years. ILCs have now been shown to regulate defenses to infections, wound healing, allergy and adaptive immunity through their prompt reactivity to tissue infection and injury. Thus harnessing the activity of ILCs may lead to improved immunotherapy and vaccines, an expectation that is reflected in the growing number of high impact papers published in top-tier journals and of teams investigating ILC biology worldwide.

It appears therefore well timed to organize the first international meeting on ILCs this year in order to gather all major players in the field and discuss recent advances and visions, as well as to reconvene this meeting every 2-3 years in order to monitor progress and re-assess the larger picture in ILC research. 

 

Chairs of the conference

James Di Santo, Institut Pasteur, Paris, France

Gérard Eberl, Institut Pasteur, Paris, France

Eric Vivier, Centre d'Immunologie de Marseille-Luminy, France 

 

Scientific committee

David Artis, UPenn, Philadelphia, USA
Marco Colonna, Washington University, St Louis, USA

Andreas Diefenbach, Freiburg University, Germany  

Shigeo Koyasu, Riken Yokohama, Japan 

Richard Locksley, UCSF, San Francisco, USA 

Andrew McKenzie, LMB, Cambridge, UK
Reina Mebius, Vrije Universiteit, Amsterdam, The Netherlands
Fiona Powrie, University of Oxford, UK 
Hergen Spits, University of Amsterdam, The Netherlands